Skip to content
Blerp – Lifestyle
Author:
Italfarmaco
Italfarmaco Announces Health Canada Acceptance and Priority Review of New Drug Submission for Givinostat as a Duchenne Muscular Dystrophy Treatment
June 10, 2026